Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 85901-85950 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05408559
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
PHASE1/PHASE2Recruiting
200 participants
Started: Jul 1, 2022 · Completed: Jul 30, 2026
3 conditions1 sponsor1 location
NCT05433935
Exploring Biomarkers of the Carcinogenesis of Intraductal Papillary Mucinous Neoplasm (IPMN) of the Pancreas
N/ARecruiting
5,000 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2033
1 condition5 sponsors1 location
NCT05390047
The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI)
N/ARecruiting
4,000 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2025
1 condition4 sponsors1 location
NCT05314400
Gadoxetate Abbreviated MRI in Metastatic Colorectal Cancer
NARecruiting
200 participants
Started: Jul 1, 2022 · Completed: Oct 1, 2027
1 condition2 sponsors2 locations
NCT05048251
Individually Targeted Neuromodulation for Contamination-based OCD
NARecruiting
50 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2024
1 condition2 sponsors1 location
NCT06238063
Implementing a Nurse-led Advance Care Planning (ACP) Intervention in Residential Care Homes
NARecruiting
164 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05065372
MANATEE-T1D: Metformin ANd AutomaTEd Insulin Delivery System Effects on Renal Vascular Resistance, Insulin Sensitivity, and Cardiometabolic Function in Youth With Type 1 Diabetes
PHASE1Recruiting
60 participants
Started: Jul 1, 2022 · Completed: Jul 31, 2027
5 conditions3 sponsors2 locations
NCT06125249
Humanin's Value for Early Diagnosis and Short-term Prognosis in Patients With AKI After Heart Transplantation
N/ARecruiting
60 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2024
2 conditions1 sponsor1 location
NCT06250595
European Rare Blood Disorders Platform (ENROL)
N/ARecruiting
37,090 participants
Started: Jul 1, 2022 · Completed: Jul 31, 2037
12 conditions2 sponsors1 location
NCT05380271
Efficacy and Safety of DEB-BACE With Sequential Arotinib and Tirelizumab in the Treatment of Advanced NSCLC
PHASE2Not yet recruiting
60 participants
Started: Jul 1, 2022 · Completed: Dec 1, 2025
1 condition1 sponsor0 locations
NCT06215092
Perinatal and Psychological Correlates of Neurodevelopmental Disorders in Children.
N/ARecruiting
500 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT04462458
M-ARS ACL Post-marketing Surveillance Study
N/ARecruiting
200 participants
Started: Jul 1, 2022 · Completed: Jan 31, 2027
1 condition1 sponsor3 locations
NCT06063005
Clinical Study of Translocated Internal Limiting Membrane Flap Reposition for the Treatment of Idiopathic Macular Hole
NARecruiting
76 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2025
1 condition2 sponsors1 location
NCT05411744
One-month Latent Tuberculosis Treatment for Renal Transplant Candidates
PHASE4Recruiting
25 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2029
4 conditions1 sponsor1 location
NCT05428137
Study of Safety and Efficacy of a Probiotic and Postbiotic in Overweight Individuals
NARecruiting
180 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05597709
Prevalence of MAFLD in Patients With Type 2 Diabetes in Jiangsu Province of China
N/ARecruiting
2,900 participants
Started: Jul 1, 2022 · Completed: Jun 1, 2027
2 conditions12 sponsors1 location
NCT04278261
Comparison H-FIRE and Laparoscopic RP in Treating Men With Localized Prostate Cancer
NANot yet recruiting
216 participants
Started: Jul 1, 2022 · Completed: Sep 1, 2026
2 conditions1 sponsor1 location
NCT05911165
Impact of Surgical Coaching on Resident ObGyn Laparoscopic Skills
NAActive, not recruiting
28 participants
Started: Jul 1, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04565795
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
NARecruiting
87 participants
Started: Jul 1, 2022 · Completed: Sep 30, 2026
1 condition2 sponsors4 locations
NCT05230758
Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
PHASE3Recruiting
140 participants
Started: Jul 1, 2022 · Completed: Jun 30, 2027
2 conditions1 sponsor19 locations
NCT05663788
Web-based Learning Module on Optical Diagnosis of Early Colorectal Cancer
NARecruiting
166 participants
Started: Jul 1, 2022 · Completed: Mar 31, 2024
2 conditions4 sponsors12 locations
NCT05306145
Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia
NARecruiting
118 participants
Started: Jun 30, 2022 · Completed: Apr 1, 2026
1 condition1 sponsor1 location
NCT05399433
Role of Glucose Metabolism in Migration of Cutaneous Dendritic Cells in Psoriasis
NARecruiting
100 participants
Started: Jun 30, 2022 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05439811
Retrospective Data Analysis on the Application of Swan-Ganz Catheter in Cardiac Surgery
N/ANot yet recruiting
3,000 participants
Started: Jun 30, 2022 · Completed: Dec 30, 2025
1 condition2 sponsors0 locations
NCT05420779
A Study to Evaluate the Efficacy and Safety of TSL-1502 Capsules in Breast Cancer Patients With Germline BRCA Mutations
PHASE2Recruiting
125 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05040178
An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics
N/ARecruiting
20 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2032
3 conditions2 sponsors5 locations
NCT05208879
CArotenoid in hypoChOlesterolemia
N/ARecruiting
40 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor3 locations
NCT05163054
Cohort Study of Patients With Type 1 Diabetes Registered With Mobile Application in China
N/ANot yet recruiting
500 participants
Started: Jun 30, 2022 · Completed: Jan 31, 2032
1 condition1 sponsor1 location
NCT05383482
Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1
PHASE1/PHASE2Active, not recruiting
22 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor5 locations
NCT05788614
Retroversion in Reverse Shoulder Arthroplasty
NARecruiting
90 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05437315
GD2/PSMA Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05483816
MultiSENSory Stimulation to TArgeT Sensory Loss and ChronIc Pain in NeurOpathic PatieNts
NARecruiting
40 participants
Started: Jun 30, 2022 · Completed: Feb 28, 2028
5 conditions2 sponsors1 location
NCT05364073
Study of Furmonertinib in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Activating, Including Uncommon, Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Mutations
PHASE1Active, not recruiting
160 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor42 locations
NCT05437341
PSMA/CD70 Bi-specific CAR-T Cell Therapy
PHASE1/PHASE2Recruiting
60 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05353322
Breaking up Prolonged Sedentary Behavior to Improve Cardiometabolic Health
NARecruiting
324 participants
Started: Jun 30, 2022 · Completed: Mar 31, 2026
4 conditions2 sponsors1 location
NCT05736146
Validating Gulf War Illness Blood Biomarkers
N/ARecruiting
100 participants
Started: Jun 30, 2022 · Completed: Mar 1, 2026
2 conditions4 sponsors3 locations
NCT05299502
Healthy Eating in Women at Risk of Gestational Diabetes
NAActive, not recruiting
150 participants
Started: Jun 30, 2022 · Completed: Feb 28, 2027
2 conditions3 sponsors1 location
NCT05513755
Cardioneuroablation in Reflex Syncope (CARDIOSYRE Trial)
NARecruiting
92 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
1 condition18 sponsors1 location
NCT04991116
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
PHASE3Recruiting
650 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2029
1 condition1 sponsor97 locations
NCT05456425
A Clinical Trial on Safety and Efficacy of CBT-001 in Patients With Pterygium
PHASE3Active, not recruiting
660 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor44 locations
NCT05350332
Effects of Lung Volume on Upper Airway Patency During Drug Induced Sleep Endoscopy
NARecruiting
200 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05282147
Digital Imaging Versus Ophthalmoscopy
NANot yet recruiting
140,000 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor0 locations
NCT05334667
CRRT Versus Plasmapheresis in Aluminum Phosphide Poisoning
NANot yet recruiting
75 participants
Started: Jun 30, 2022 · Completed: Nov 30, 2025
1 condition1 sponsor0 locations
NCT06024694
Primary Mediastinal Large B-cell Lymphoma With CNS Involvement
N/AActive, not recruiting
45 participants
Started: Jun 30, 2022 · Completed: Jun 10, 2027
1 condition1 sponsor1 location
NCT05037305
VICE-MPRINT: Maternal and Pediatric Pharmacogenetics Survey
NARecruiting
500 participants
Started: Jun 30, 2022 · Completed: Oct 30, 2025
1 condition1 sponsor2 locations
NCT04042844
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
PHASE2Recruiting
99 participants
Started: Jun 30, 2022 · Completed: Dec 31, 2027
1 condition1 sponsor19 locations
NCT05076682
Reverse Triple Negative Immune Resistant Breast Cancer
PHASE2Recruiting
70 participants
Started: Jun 30, 2022 · Completed: Mar 31, 2027
1 condition1 sponsor1 location
NCT06088576
Using a Digital Application for Adolescents in Dropout of Care in Mental Health : Facilitate the Return in Classic Care With Telepsychiatry, Tchats, Forums and a Home Medical Team.
NARecruiting
50 participants
Started: Jun 30, 2022 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05418088
Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies
PHASE1Recruiting
54 participants
Started: Jun 30, 2022 · Completed: Jul 31, 2026
18 conditions2 sponsors2 locations
NCT05244551
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK061 in Patients With Advanced Solid Tumors
PHASE1Recruiting
85 participants
Started: Jun 30, 2022 · Completed: Apr 30, 2025
1 condition1 sponsor22 locations